USE OF EGFR/HER2 RECEPTOR TYROSINE KINASE INHIBITOR IN PREPARING DRUGS FOR TREATING CANCERS INDUCED BY HER2 MUTATION

The present invention relates to the use of an EGFR/HER2 receptor tyrosine kinase inhibitor in preparing drugs for treating cancers induced by HER2 mutation. In particular, the present invention relates to the use of a compound as shown in formula A or a pharmaceutically acceptable salt thereof in p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	REN, Shengxiang, ZENG, Xiaoling, YANG, Changyong, ZHOU, Caichun, ZHANG, Ge, CAO, Guoqing, ZOU, Jianjun, HUANG, Yaling
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the use of an EGFR/HER2 receptor tyrosine kinase inhibitor in preparing drugs for treating cancers induced by HER2 mutation. In particular, the present invention relates to the use of a compound as shown in formula A or a pharmaceutically acceptable salt thereof in preparing drugs for treating cancers induced by HER2 mutation.